Niveles de vitamina D en pacientes con osteoporosis en la ciudad de Neiva, Huila, Colombia
PDF (Español (España))
HTML (Español (España))

Keywords

Vitamina D
hormona paratiroidea
calcio
25-hidroxivitamina D
osteoporosis
parathyroid hormone
calcium
25-Hydroxyvitamin D
Vitamin D

How to Cite

Pinzón Tovar, A., Vásquez, N., & Celemin, C. (2017). Niveles de vitamina D en pacientes con osteoporosis en la ciudad de Neiva, Huila, Colombia. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 2(3), 44–50. https://doi.org/10.53853/encr.2.3.95

Abstract

Objetivos: Determinar la prevalencia de los niveles bajos de vitamina D en pacientes con diagnóstico de osteoporosis por densitometría ósea en la ciudad de Neiva, Huila, Colombia.
Materiales y métodos: Se incluyeron pacientes mayores de 50 años, durante el periodo comprendido entre el 01 de enero de 2011 hasta el 31 de diciembre de 2011, con diagnóstico de osteoporosis por densitometría y reporte de 25 OH hidroxivitamina D medida por quimioluminiscencia que consultaron al hospital universitario de la ciudad de Neiva. Se establecieron medidas de posible asociación entre variables cuantitativas (Odds Ratio) y se planteó un modelo de regresión lineal en el cual se determinó la variable independiente que mejor predice el resultado de la variable dependiente, para así poder observar la correlación existente. El análisis estadístico se realizó bajo el paquete SPSS versión 19.
Resultados: La hipovitaminosis D es un trastorno muy frecuente en la población estudiada (89%) y en el 55% de los casos se acompaña de hiperparatiroidismo secundario. Se encontró una prevalencia de niveles de deficiencia del 35,5% (n= 20), de insuficiencia del 53,5% (n= 30) y óptimos del 11% (n= 6). Al realizar un análisis bivariado de la densidad mineral ósea (DMO) y los niveles de vitamina D, se observó que la DMO descendía simultáneamente con la caída en los niveles séricos de vitamina D. Esta asociación fue estadísticamente significativa a nivel de la columna lumbar p= 0,0063.
Conclusiones: La insuficiencia y la deficiencia de vitamina D son muy frecuentes aun en zonas donde la exposición solar es diaria durante todo el año, lo que hace necesario realizar su determinación en todos los pacientes con osteoporosis.

Abstract
Objective: Determine the prevalence of vitamin D levels in patients diagnosed by bone densitometry for osteoporosis inNeiva, Huila, Colombia.

Material and methods: Patients older than 50 years were included during the period from January 1, 2011 until December 31, 2011 , with a diagnosis of osteoporosis by densitometry and reporting of 25 -OH vitamin D by chemiluminescence, who attended the university hospital Neiva. Measures possible association between qualitative variables (Odds Ratio) is established and a linear regression model in which the independent variable that best predicts the outcome of the dependent variable, and observe the correlation was determined. Statistical analysis was performed on SPSS version 19 package.
Results: Hypovitaminosis D is a very common disorder in the study population (89%) and in 55% of cases is associated with secondary hyperparathyroidism. Prevalence of deficiency levels of 35.5% (n = 20), insufficiency of 53.5% (n = 30) and optimal11% ( n = 6 ) were found. When performing a bivariate analysis of the levels of bone mineral density (BMD) and vitamin D levels, we found that bone mineral density down simultaneously with the fall in serum levels of vitamin D. This association was statistically significant at the level of lumbar spine p = 0.0063.
Conclusion: Insufficiency and deficiency of vitamin D is very common even in areas where sun exposure is daily throughout the year, making it necessary to perform testing in all patients with osteoporosis.

https://doi.org/10.53853/encr.2.3.95
PDF (Español (España))
HTML (Español (España))

References

1. Adams J S, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010;95:471-478.
2. Gilaberte Y, Aguilera, Carrascosa JM, Figueroa F L, Romani de Gabriel J. La vitamina D: evidencias y controversias. Actas Dermosifiliogr 2011;102(8):572-588.
3. Holick M F. Vitamin D: Extraskeletal Health. Endocrinol Metab Clin N Am 2010;39:381–400.
4. García Vadillo J A. Suplementos de calcio y vitamin D ¿para todos?: Pros. Reumatol Clin. 2011;7(S2):S34–S39.
5. McMillan, Hicks J, Isabella C, Higa G M. A critical analysis of the (near) Legendary Status of vitamin D. Expert Rev Endocrinol Metab 2012;7:103-119.
6. Holick M F, Neil C. Binkley N C, Bischoff-Ferrari H A, Gordon C M, Hanley D A, Heaney R P, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96: 1911-1930.
7. Stechschulte S A, Kirsner R S, Federman D G. Vitamin D: Bone and Beyond, Rationale and Recommendations for Supplementation. Am J Med 2009;122:793-802.
8. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 20:1807-20.
9. National Osteoporosis Foundation. Clinician’s Guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
10. González Luis Alonso, Vásquez Gloria María, Molina José Fernando. Epidemiología de la osteoporosis. Rev. Colomb. Reumatol. Vol. 16 No. 1, Marzo 2009, pp. 61-75.
11. Ching Pontón R B, Paba García M L, Ibáñez de Rosa B, Del Valle Meza R, Benavides Burbano A, Iglesias Rodríguez A et al. Factores de riesgo para osteoporosis y osteopenia en 707 mujeres seleccionadas en Bogotá. REEMO, Vol. 10. Núm. 3, Mayo-Junio 2001.
12. Institute for Clinical Systems Improvement. Health Care Guideline: Diagnosis and Treatment of Osteoporosis Guideline. Seventh edition July 2011.
13. Briot K, et al. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine (2012), doi:10.1016/j.jbspin.2012.02.014.
14. Prevention and management of osteoporosis: report of a WHO Scientific Group. Geneva, Switzerland; 2003.
15. Chang K, Center J, Nguyen, et al. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology
Study. J Bone Miner Res 2004; 19: 532-536.
16. Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR, et al. The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int. 2009; 2: 275-282.
17. Morales Torres J & Gutierrez-Urena S. The burden of osteoporosis in Latin America. Osteoporos Int 2004; 15: 625-632.
18. Chapuy M, Arlot M, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and Calcium to prevent hip fractures in elderly women. N Engl J Med
1992;327:1637-42.
19. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch Intern Med 2009;169:551–561.
20. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.
21. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
22. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257– 2264.
23. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson- Hughes B. Fracture prevention with vitamin D supplementation: a
meta-analysis of randomized controlled trials. JAMA 2005;293:2257–2264.
24. Goswami R, Mishra S.K, Kochupillai N. Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 127, March 2008, pp 229-238.
25. Holick MF, Siris ES, Binkley N et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215–3224.
26. González Devia D, Zúñiga Libreros C, Kattah Calderón W. Insuficiencia de vitamina D en pacientes adultos con baja masa ósea y osteoporosis en la Fundación Santa Fe de Bogotá 2008-2009. Rev. Colomb. Reumatol. 2010;Vol. 17 No. 4: 212-218.
27. Molina J.F, Molina J, Escobar J.A, Betancur J.F, Giraldo A. Niveles de 25 hidroxivitamina D y su correlación clínica con diferentes variables metabólicas y cardiovasculares en una población de mujeres posmenopáusicas. Acta Med Colomb 2011; 36: 18-23.
28. Gilchrest Barbara A. Sun exposure and vitamin D sufficiency. Am J Clin Nutr 2008;88(suppl):570S–577S.
29. Holick M F. Vitamin D: A Millenium Perspective. Journal of Cellular Biochemistry 2003; 88:296–307.
30. Holick M F. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
31. Ubeda N, Basagoiti M, Alonso-Aperte E, Varela-Moreiras G. Dietary food habits, nutritional status and lifestyle in menopausal women in Spain. Nutr Hosp. 2007;22:313–321.
32. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:373-378.
33. Holick M. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S-1688S.
34. Matsuoka L Y, Wortsman J, Haddad J G, Kolm Paul, Hollis B W. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 1991;127:536-538.
35. MacLaughlin J, Holick M F. Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest 1985;76:1536-1538.
36. Matsuoka LY, Wortsman J, Dannenberg MJ, Hollis BW, Lu Z, Holick MF. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab 1992;75:1099-103.
37. Matsuoka LY, Ide L, Wortsman J, MacLaughlin J, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165.-1168.
38. Pabón G, Calpa C, Jaramillo M, Pinto R. Modélo geológico y geotécnico de Neiva. VIII CCG 2000- Sociedad Colombiana de Geotecnia.
39. Rodríguez J, Gonzáles C, Patricio M. Fracturas vertebrales, osteoporosis y vitamina D en la posmenopausia. Estudio en 555 mujeres en Chile. Rev Med Chile 2007; 135: 31-36.
40. Sotelo Wendy, Calvo Armando. Niveles de vitamina D en mujeres posmenopáusicas con osteoporosis primaria. Rev Med Hered 2011; 22;10-14.
41. Rosen C J. Vitamin D Insufficiency. N Engl J Med 2011;364:248-254.
42. Lips P, Hosking D, Lippuner K et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006;260:245–254.
43. Kumar J, Muntner P, Kaskel F J, Hailpern S M, Melamed M L. Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004. PEDIATRICS 2009;124:e1-e9.
44. Van der Mei Ingrid A.F, Ponsonby Anne-Louise, Engelsen Ola, Pasco Julie A, McGrath John J, Eyles Daryl W, et al. The High Prevalence of Vitamin D Insufficiency across Australian Populations Is Only Partly Explained by Season and Latitude. Environ Health Perspect. 2007;115:1132–1139.
45. Hanley D A, Cranney A, Jones G, Whiting S J, Leslie W D. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 2010;182(12):1315-1319.
46. Van den Bergh J p, Bours S P, Van Geel T A, Geusens P P. Optimal Use of Vitamin D When Treating Osteoporosis. Curr Osteoporos Rep 2011;9:36–42
47. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439–443.
48. Kim S.H; Kim T.H; Kim, S.K. Effect of high parathyroid hormone level on bone mineral density in vitamin D-Sufficiency population: Korea National
Health and Nutrition Examination Survey 2008-2010. (25/12/2014).Vol 61 Nr. 12 Pagina: 1197 – 204.
49. Thomas KK, Lloyd-Jones DM, Thadhani R I, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-83.
50. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004;35:312–319.
51. Vacet J L, Vanga S R, Good M, Lai S M, Lakkireddy D, Howard P. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012;109(3):359-363.
52. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic metaregression analysis. Osteoporos Int. 2009;20:133- 140.
53. Hartley M, Hartley M ,Hoare S, Lithander FE, Neale RE, Hart PH, et al. Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the Sun Exposure and Vitamin D Supplementation (SEDS) Study. BMC Public Health. 2015 Dec;15(1):1461. doi: 10.1186/s12889-015-1461-7. Epub 2015 Feb 10
54. Kimlin MG, Lucas RM, Harrison SL, van der Mei I, Armstrong BK, Whiteman DC, et al. The Contributions of Solar Ultraviolet Radiation Exposure and Other Determinants to Serum 25-Hydroxyvitamin D Concentrations in Australian Adults: The AusD Study. Am J Epidemiol. 2014;179(7):864–74
55. Adachi JD, Brown JP, Ioannidis G, Characterizing the assessment and management of vitamin D levels in patients with osteoporosis in clinical practice: a chart review initiative. J Osteoporos. 2015.

Authors must state that they reviewed, validated and approved the manuscript's publication.  Moreover, they must sign a model release that should be sent.  A copy may be reviewed here

Dimensions


PlumX


Downloads

Download data is not yet available.